Prof. Dr. Dolores Cahill has completed her undergraduate studies at Trinity College, Dublin and PhD from Dublin City University. She is a world-wide renowned expert in high-throughput proteomics technology development and automation, high content protein arrays and their biomedical applications, including in biomarker discovery. Her team has achieved key breakthroughs in developing high-density protein and antibody array technologies and demonstrated their applications in biological and medical research. Prof. Cahill pioneered this research area at the Max-Planck-Institute of Molecular Genetics in Berlin, Germany, and holds several international patents in this vital field. She has received the prestigious BMBF Bio Future Award from the German Minister of Science, the Federation of European Biochemical Societies 2009 Award and co-founded Protagen AG to commercialize her discoveries. Prof. Cahill is Professor of Translational Science at the Conway Institute, School of Medicine and Medical Sciences at the University College Dublin. She has authored many publications and attended international conferences.

Her research interest focuses on integration of proteomics and recombinant protein and antibody arrays and technology development to advance research programmes in the areas of Oncology, Inflammation, Neurobiology and Cardiovascular disease, collections of recombinant proteins using protein expression/cDNA library technology and its application to cell biology and biomedicine. Her team is currently developing new applications in Nanotechnology, large scale biology and developing compound - protein interaction technologies.